These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19557469)
21. The role of adjuvant chemotherapy for locally advanced bladder cancer. Lehmann J; Retz M; Stöckle M World J Urol; 2001 Apr; 19(2):133-40. PubMed ID: 11374316 [TBL] [Abstract][Full Text] [Related]
22. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135 [TBL] [Abstract][Full Text] [Related]
23. [First line therapy for locally advanced or metastatic urothelial cancer : A randomized double blind phase III multicenter study on adjuvant nivolumab therapy versus placebo in patients with invasive high-risk urothelial cancer (CheckMate 274)-AB 58/17 of the AUO]. Rexer H; Ohlmann CH; Gschwend J; Urologe A; 2017 Oct; 56(10):1331-1332. PubMed ID: 28779222 [No Abstract] [Full Text] [Related]
24. Perioperative chemotherapy in advanced bladder cancer: part I. Neoadjuvant treatment. Goebell PJ; Otto T; Rübben H Onkologie; 2003 Aug; 26(4):361-5. PubMed ID: 12972704 [TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care? Mazhar D; Ali N; Ngan S Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495 [No Abstract] [Full Text] [Related]
33. Targeted agents in second-line bladder cancer therapy. Gerullis H; Otto T; Ecke TH Anticancer Drugs; 2012 Nov; 23(10):1003-15. PubMed ID: 22914698 [TBL] [Abstract][Full Text] [Related]
34. Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope. Morales-Barrera R; Suárez C; de Castro AM; Racca F; Valverde C; Maldonado X; Bastaros JM; Morote J; Carles J Cancer Treat Rev; 2016 Nov; 50():208-216. PubMed ID: 27743530 [TBL] [Abstract][Full Text] [Related]
35. Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma. Tabayoyong W; Li R; Gao J; Kamat A Urol Clin North Am; 2018 May; 45(2):155-167. PubMed ID: 29650132 [TBL] [Abstract][Full Text] [Related]
36. Is there a role for induction therapy for locally advanced bladder cancer? Soloway MS Urology; 1987 Jun; 29(6):577-83. PubMed ID: 3576880 [No Abstract] [Full Text] [Related]
37. Neo-adjuvant and adjuvant chemotherapy in bladder cancer. D'Auria G; Ciprotti M; Conte D; Iacovelli R; Palazzo A; Pellegrino A; Cortesi E Ann Oncol; 2007 Jun; 18 Suppl 6():vi162-3. PubMed ID: 17591814 [No Abstract] [Full Text] [Related]
38. [50 years of systemic therapy of urinary bladder cancer]. Retz M; von Amsberg G; Horn T; Gschwend JE; Maisch P Aktuelle Urol; 2019 Aug; 50(4):358-365. PubMed ID: 31242517 [TBL] [Abstract][Full Text] [Related]
39. "Missing the target" in urothelial cancer. Dreicer R Oncology (Williston Park); 2013 Mar; 27(3):227, 233. PubMed ID: 23687794 [No Abstract] [Full Text] [Related]